|
gptkbp:instanceOf
|
gptkb:drug
nonsteroidal antiandrogen
|
|
gptkbp:activeEnantiomer
|
(R)-bicalutamide
|
|
gptkbp:approvedBy
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:Japan
gptkb:United_States
1995
|
|
gptkbp:ATCCode
|
gptkb:L02BB03
|
|
gptkbp:brand
|
Casodex
Bicadex
Calutide
|
|
gptkbp:CASNumber
|
90357-06-5
|
|
gptkbp:category
|
hormonal antineoplastic agent
androgen receptor antagonist
nonsteroidal antiandrogen
|
|
gptkbp:chemicalFormula
|
C18H14F4N2O4S
|
|
gptkbp:contraindication
|
gptkb:women
children
pregnancy
|
|
gptkbp:developedBy
|
gptkb:AstraZeneca
|
|
gptkbp:discoveredIn
|
1980s
|
|
gptkbp:eliminationHalfLife
|
5-7 days
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:has_stereochemistry
|
racemic mixture
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
bicalutamide
|
|
gptkbp:interactsWith
|
gptkb:warfarin
CYP3A4 substrates
|
|
gptkbp:KEGGID
|
D00294
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
androgen receptor antagonist
|
|
gptkbp:MedlinePlusID
|
a696008
|
|
gptkbp:MeSH_ID
|
gptkb:D019962
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
430.38 g/mol
|
|
gptkbp:pregnancyCategory
|
gptkb:X_(US)
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1423
2375
DB01128
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
breast tenderness
decreased libido
gynecomastia
hot flashes
erectile dysfunction
liver dysfunction
|
|
gptkbp:UNII
|
81X0I7V3A8
|
|
gptkbp:usedFor
|
prostate cancer
|
|
gptkbp:bfsParent
|
gptkb:Androgen_receptor
gptkb:androgen_receptor
|
|
gptkbp:bfsLayer
|
7
|